Clinical Trial Update: How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver [NA]

View source ↗

Summary

A clinical trial sponsored by Université de Sherbrooke is exploring whether abnormal fat-tissue function in individuals with Type 1 diabetes contributes to live…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Steatohepatitis
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Université de Sherbrooke | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH) | NA | Status: NOT_YET_RECRUITING